If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

Share Price is delayed by 15 minutes
Get Live Data
479.40    1.40 (0.29%)
Bid:
481.20
Ask:
482.00
Spread: 0.80 (0.166%)
Market Cap: £2.46b
QQ. Live PriceLast checked at - London Stock Exchange

Intraday Qinetiq Share Chart

Directorate Change

11 Jun 2025 11:00

RNS Number : 2654M
QinetiQ Group plc
11 June 2025
 

QinetiQ Group plc

Non-Executive Directorate Change

 

11 June 2025 - QinetiQ Group plc ("QinetiQ" or the "Group") today announces that Ross McEwan, who has been a Non-executive Director since March 2024, will not stand for re-election at the Group's upcoming AGM and will resign from the Board with effect from 17 July 2025.

Commenting on today's announcement, Ross McEwan said:

"I have enjoyed my time working with QinetiQ and have a deep respect for its people and the critical role they play serving the national security interests of their customers. Regretfully, I need to step down in order to devote more time and attention to my role as Chair of BHP Group Limited." 

Neil Johnson, Group Chair of QinetiQ, said:

"I would like to thank Ross for his invaluable contribution to QinetiQ's Board and his support to the Group over the past year. I understand Ross' decision to stand down and am grateful for his offer to be available on an informal basis, as his time allows, to provide the benefit of his experience in the Asia-Pacific region, to myself and the Group CEO. His insights and advice will be missed by the Board, but we greatly appreciate his continuing interest in the Group and we wish him well for his future endeavours."

This announcement is made pursuant to Listing Rule 6.4.6R. No other information is required to be disclosed pursuant to Listing Rule 6.4.8R.

S430(2B) Companies Act 2006:

Ross McEwan has not and will not receive any loss of office payments, nor will he be paid any further remuneration for his service as a Director of QinetiQ, other than fees due for his services up to the date of his retirement from the Board.

About QinetiQ:

QinetiQ is an integrated global defence and security company focused on mission-led innovation. QinetiQ employs more than 8,500 highly-skilled people, committed to creating new ways of protecting what matters most; testing technologies, systems, and processes to make sure they meet operational needs; and enabling customers to deploy new and enhanced capabilities with the assurance they will deliver the performance required.

For further information please contact:

Lindsay Walls, Group Director Communications: +44 (0) 770 720268

Stephen Lamacraft, Interim Group Investor Relations Director: +44 (0) 7570 082140

James Field, Company Secretary: +44 (0) 7841 662957

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEBLFFEQLFBBE
Date   Source Headline
12th Jun 201812:09 pmRNSDirector/PDMR Shareholding
24th May 201812:02 pmRNSHolding(s) in Company
24th May 20187:00 amRNSFull Year Results 2018
10th May 201812:24 pmRNSDirector/PDMR Shareholding
1st May 20188:01 amRNSBlock listing Interim Review
24th Apr 20187:00 amRNSAcquisition of E.I.S. Aircraft Operations
10th Apr 20181:14 pmRNSDirector/PDMR Shareholding
4th Apr 201811:40 amRNSHolding(s) in Company
29th Mar 20187:00 amRNSPre-close statement and update on LTPA
21st Mar 20183:48 pmRNSHolding(s) in Company
20th Mar 20181:49 pmRNSHolding(s) in Company
12th Mar 20181:16 pmRNSDirector/PDMR Shareholding
26th Feb 20183:31 pmRNSHolding(s) in Company
23rd Feb 20184:10 pmRNSHolding(s) in Company
15th Feb 20182:46 pmRNSHolding(s) in Company
12th Feb 20183:44 pmRNSHolding(s) in Company
12th Feb 20181:05 pmRNSDirector/PDMR Shareholding
12th Feb 201812:55 pmRNSDirector/PDMR Shareholding
9th Feb 20183:01 pmRNSDirector/PDMR Shareholding
8th Feb 20184:18 pmRNSHolding(s) in Company
8th Feb 20187:00 amRNSThird Quarter Trading Update
22nd Jan 20183:55 pmRNSHolding(s) in Company
10th Jan 201811:08 amRNSDirector/PDMR Shareholding
12th Dec 20173:55 pmRNSDirector/PDMR Shareholding
6th Dec 201712:42 pmRNSHolding(s) in Company
20th Nov 201712:25 pmRNSDirector/PDMR Shareholding
20th Nov 201710:59 amRNSDirector/PDMR Shareholding
20th Nov 201710:53 amRNSDirector/PDMR Shareholding
16th Nov 20177:00 amRNSInterim Results
10th Nov 20173:57 pmRNSDirector/PDMR Shareholding
1st Nov 20178:19 amRNSBlock listing Interim Review
18th Oct 20174:46 pmRNSHolding(s) in Company
10th Oct 20174:03 pmRNSHolding(s) in Company
10th Oct 201712:39 pmRNSDirector/PDMR Shareholding
6th Oct 20174:35 pmRNSHolding(s) in Company
29th Sep 20177:00 amRNSPre-Close Trading Statement
22nd Sep 20178:08 amRNSDirector/PDMR Shareholding
12th Sep 20172:08 pmRNSDirector/PDMR Shareholding
8th Sep 201710:43 amRNSDirector/PDMR Shareholding
5th Sep 20171:51 pmRNSHolding(s) in Company
4th Sep 20171:02 pmRNSDirector/PDMR Shareholding
4th Sep 201710:27 amRNSHolding(s) in Company
23rd Aug 201712:02 pmRNSHolding(s) in Company
22nd Aug 20174:19 pmRNSHolding(s) in Company
14th Aug 20173:52 pmRNSDirector/PDMR Shareholding
26th Jul 201712:23 pmRNSDirector/PDMR Shareholding
25th Jul 20173:43 pmRNSDirector/PDMR Shareholding
25th Jul 20179:41 amRNSDirector/PDMR Shareholding
24th Jul 20175:09 pmRNSDirector/PDMR Shareholding
24th Jul 20172:31 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.